Does acute caffeine ingestion alter brain metabolism in young adults?

NeuroImage

Volumn 110, Issue , 2015, Pages 39-47

  Xu, Feng ^a,b,c   Liu, Peiying ^a,b   Pekar, James J ^b,c   Lu, Hanzhang ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Caffeine; Cerebral blood flow; Cerebral metabolic rate of oxygen; Cerebral venous oxygenation; Oxygen extraction fraction; TRUST MRI

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD LEVEL; BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN METABOLISM; CEREBRAL METABOLIC RATE OF OXYGEN; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FOOD INTAKE; FRONTAL CORTEX; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; MALE; MEDIAL FRONTAL CORTEX; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN EXTRACTION FRACTION; POSTERIOR CINGULATE; PREFRONTAL CORTEX; SPIN LABELING; SUPERIOR TEMPORAL SULCUS; VOXEL BASED MORPHOMETRY; WHITE MATTER; YOUNG ADULT; BLOOD; BRAIN; DRUG EFFECTS; METABOLISM; OXYGEN CONSUMPTION;

ADULT; BRAIN; BRAIN MAPPING; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN CONSUMPTION; YOUNG ADULT;

EID: 84922374057     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.01.046     Document Type: Article

References (52)

1. Addicott M.A., Yang L.L., Peiffer A.M., Burnett L.R., Burdette J.H., Chen M.Y., Hayasaka S., Kraft R.A., Maldjian J.A., Laurienti P.J. The effect of daily caffeine use on cerebral blood flow: how much caffeine can we tolerate?. Hum. Brain Mapp. 2009, 30:3102-3114.
2. Alsop D.C., Detre J.A., Golay X., Gunther M., Hendrikse J., Hernandez-Garcia L., Lu H., Macintosh B.J., Parkes L.M., Smits M., van Osch M.J., Wang D.J., Wong E.C., Zaharchuk G. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn. Reson. Med. 2014, (Apr 8). 10.1002/mrm.25197.
3. Attwell D., Laughlin S.B. An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 2001, 21:1133-1145.
4. Bakker C.J., Hoogeveen R.M., Viergever M.A. Construction of a protocol for measuring blood flow by two-dimensional phase-contrast MRA. J. Magn. Reson. Imaging 1999, 9:119-127.
5. Berkowitz B.A., Spector S. The effect of caffeine and theophylline on the disposition of brain serotonin in the rat. Eur. J. Pharmacol. 1971, 16:322-325.
6. Berkowitz B.A., Tarver J.H., Spector S. Release of norepinephrine in the central nervous system by theophylline and caffeine. Eur. J. Pharmacol. 1970, 10:64-71.
7. Cameron O.G., Modell J.G., Hariharan M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci. 1990, 47:1141-1146.
8. Chen Y., Parrish T.B. Caffeine's effects on cerebrovascular reactivity and coupling between cerebral blood flow and oxygen metabolism. Neuroimage 2009, 44:647-652.
9. Chen Y., Newberg A.B., Wang J., Rao H., An H., Greenberg J., Wintering N., Toles V., Detre J.A. Caffeine's effects on resting-state oxygen and glucose metabolism: a combined MR and PET study. Proceedings of 17th annual meeting of international society for magnetic resonance in medicine, Hawaii, USA 2009, 794.
10. Di W., Shi X., Zhu Y., Tao Y., Qi W., Luo N., Xiao Z., Yi C., Miao J., Zhang A., Zhang X., Fang Y. Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients. Eur. J. Neurol. 2013, 20:655-662.
11. Dimpfel W., Schober F., Spuler M. The influence of caffeine on human EEG under resting conditions and during mental loads. Clin. Investig. 1993, 71:197-207.
12. Donahue M.J., Lu H., Jones C.K., Pekar J.J., van Zijl P.C. An account of the discrepancy between MRI and PET cerebral blood flow measures. A high-field MRI investigation. NMR Biomed. 2006, 19:1043-1054.
13. Evans A.J., Iwai F., Grist T.A., Sostman H.D., Hedlund L.W., Spritzer C.E., Negro-Vilar R., Beam C.A., Pelc N.J. Magnetic resonance imaging of blood flow with a phase subtraction technique. In vitro and in vivo validation. Invest. Radiol. 1993, 28:109-115.
14. Ferre S. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J. Alzheimers Dis. 2010, 20(Suppl. 1):S35-S49.
15. Fredholm B.B., Battig K., Holmen J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999, 51:83-133.
16. Gallichan D., Jezzard P. Variation in the shape of pulsed arterial spin labeling kinetic curves across the healthy human brain and its implications for CBF quantification. Magn. Reson. Med. 2009, 61:686-695.
17. Golay X., Silvennoinen M.J., Zhou J., Clingman C.S., Kauppinen R.A., Pekar J.J., van Zijl P.C. Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle. Magn. Reson. Med. 2001, 46:282-291.
18. Goodman R.R., Synder S.H. Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine. J. Neurosci. 1982, 2:1230-1241.
19. Griffeth V.E., Perthen J.E., Buxton R.B. Prospects for quantitative fMRI: investigating the effects of caffeine on baseline oxygen metabolism and the response to a visual stimulus in humans. Neuroimage 2011, 57:809-816.
20. Guyton A.C., Hall J.E. Respiration. Textbook of Medical Physiology 2005, Saunders, Elsevier. A.C. Guyton, J.E. Hall (Eds.).
21. Haccke E.M., Brown R.W., Thompson M.R., Venkatesan R. MR Angiography and Flow Quantification. Magnetic Resonance Imaging: Physical Principles and Sequence Design 1999, Wiley-Liss, New York, NY.
22. Herscovitch P., Raichle M.E. What is the correct value for the brain-blood partition coefficient for water?. J. Cereb. Blood Flow Metab. 1985, 5:65-69.
23. Jain V., Langham M.C., Wehrli F.W. MRI estimation of global brain oxygen consumption rate. J. Cereb. Blood Flow Metab. 2010, 30:1598-1607.
24. Kamimori G.H., Karyekar C.S., Otterstetter R., Cox D.S., Balkin T.J., Belenky G.L., Eddington N.D. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int. J. Pharm. 2002, 234:159-167.
25. Kennedy D.O., Haskell C.F. Cerebral blood flow and behavioural effects of caffeine in habitual and non-habitual consumers of caffeine: a near infrared spectroscopy study. Biol. Psychol. 2011, 86:298-306.
26. Kety S.S., Schmidt C.F. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J. Clin. Invest. 1948, 27:484-492.
27. Laurienti P.J., Field A.S., Burdette J.H., Maldjian J.A., Yen Y.F., Moody D.M. Dietary caffeine consumption modulates fMRI measures. Neuroimage 2002, 17:751-757.
28. Liu T.T., Behzadi Y., Restom K., Uludag K., Lu K., Buracas G.T., Dubowitz D.J., Buxton R.B. Caffeine alters the temporal dynamics of the visual BOLD response. Neuroimage 2004, 23:1402-1413.
29. Liu P., Xu F., Lu H. Test-retest reproducibility of a rapid method to measure brain oxygen metabolism. Magn. Reson. Med. 2013, 69:675-681.
30. Lu H., Ge Y. Quantitative evaluation of oxygenation in venous vessels using T2-Relaxation-Under-Spin-Tagging MRI. Magn. Reson. Med. 2008, 60:357-363.
31. Lu H., Xu F., Grgac K., Liu P., Qin Q., van Zijl P. Calibration and validation of TRUST MRI for the estimation of cerebral blood oxygenation. Magn. Reson. Med. 2012, 67:42-49.
32. Lunt M.J., Jenkinson D.F., Kerr D. Transcranial Doppler blood velocity measurement-the effect of changes in velocity profile. Ultrasound Med. Biol. 2000, 26:1145-1151.
33. Lunt M.J., Ragab S., Birch A.A., Schley D., Jenkinson D.F. Comparison of caffeine-induced changes in cerebral blood flow and middle cerebral artery blood velocity shows that caffeine reduces middle cerebral artery diameter. Physiol. Meas. 2004, 25:467-474.
34. Magill R.A., Waters W.F., Bray G.A., Volaufova J., Smith S.R., Lieberman H.R., McNevin N., Ryan D.H. Effects of tyrosine, phentermine, caffeine d-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr. Neurosci. 2003, 6:237-246.
35. Mathew R.J., Wilson W.H. Caffeine induced changes in cerebral circulation. Stroke 1985, 16:814-817.
36. 11C]TMSX PET. Synapse 2007, 61:778-784.
37. Nehlig A., Daval J.L., Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev. 1992, 17:139-170.
38. Oja J.M., Gillen J.S., Kauppinen R.A., Kraut M., van Zijl P.C. Determination of oxygen extraction ratios by magnetic resonance imaging. J. Cereb. Blood Flow Metab. 1999, 19:1289-1295.
39. Park C.A., Kang C.K., Son Y.D., Choi E.J., Kim S.H., Oh S.T., Kim Y.B., Park C.W., Cho Z.H. The effects of caffeine ingestion on cortical areas: functional imaging study. Magn. Reson. Imaging 2014, 32:366-371.
40. Pelligrino D.A., Xu H.L., Vetri F. Caffeine and the control of cerebral hemodynamics. J. Alzheimers Dis. 2010, 20(Suppl. 1):S51-S62.
41. Premont J., Perez M., Blanc G., Tassin J.P., Thierry A.M., Herve D., Bockaert J. Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution. Mol. Pharmacol. 1979, 16:790-804.
42. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
43. Rodgers Z.B., Jain V., Englund E.K., Langham M.C., Wehrli F.W. High temporal resolution MRI quantification of global cerebral metabolic rate of oxygen consumption in response to apneic challenge. J. Cereb. Blood Flow Metab. 2013, 33:1514-1522.
44. Siepmann M., Kirch W. Effects of caffeine on topographic quantitative EEG. Neuropsychobiology 2002, 45:161-166.
45. Silvennoinen M.J., Clingman C.S., Golay X., Kauppinen R.A., van Zijl P.C. Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7Tesla. Magn. Reson. Med. 2003, 49:47-60.
46. Specterman M., Bhuiya A., Kuppuswamy A., Strutton P.H., Catley M., Davey N.J. The effect of an energy drink containing glucose and caffeine on human corticospinal excitability. Physiol. Behav. 2005, 83:723-728.
47. Tal O., Diwakar M., Wong C.W., Olafsson V., Lee R., Huang M.X., Liu T.T. Caffeine-induced global reductions in resting-state BOLD connectivity reflect widespread decreases in MEG connectivity. Front. Hum. Neurosci. 2013, 7:63.
48. Vago D.R., Silbersweig D.A. Self-awareness, self-regulation, and self-transcendence (S-ART): a framework for understanding the neurobiological mechanisms of mindfulness. Front. Hum. Neurosci. 2012, 6:296.
49. Wong C.W., Olafsson V., Tal O., Liu T.T. Anti-correlated networks, global signal regression, and the effects of caffeine in resting-state functional MRI. Neuroimage 2012, 63:356-364.
50. Xu F., Ge Y., Lu H. Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn. Reson. Med. 2009, 62:141-148.
51. Xu F., Uh J., Liu P., Lu H. On improving the speed and reliability of T(2)-relaxation-under-spin-tagging (TRUST) MRI. Magn. Reson. Med. 2012, 68(1):198-204.
52. Zananiri F.V., Jackson P.C., Goddard P.R., Davies E.R., Wells P.N. An evaluation of the accuracy of flow measurements using magnetic resonance imaging (MRI). J. Med. Eng. Technol. 1991, 15:170-176.